ALK (ALKB.DC / OMX: ALK B) will publish its results for the first nine months (Q3) of 2025 in the morning on Thursday, 13 November 2025.

Compelling kidney function data from VIVIAD Phase 2b study presented in late-breaking poster at ASN kidney week, the world’s premier nephrology meeting VIVIAD analyses continue to support ...

Zealand Pharma conference call on November 13 at 2pm CET (8am ET) to present third quarter 2025 financial results ...

Novo Nordisk currently expects an estimated negative low single-digit impact on global sales growth in 2026 ...

Post procedure mean minimum stent area (MSA) was 6.89 mm², exceeding the powered performance goal (PG) of 4.9 mm² (p < 0.0001), derived from previous IVL and rotational atherectomy device studies ...

Channel Medsystems, a commercial-stage women’s health company, announced today that more than 5,000 women have now been treated with the Cerene® Cryotherapy Device, underscoring the growing clinical ...

EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solution ...

The portal gives customers instant access to both their online and offline purchases and enables them to reorder products directly from any previous order with just one click. By digitizing offline ...

This follows LTC ACO’s achievement of generating one of the highest savings per beneficiary rates nationally in 2024, as previously reported, with total savings of over $66.2 million and earned ...

Bilateral kidney injection with rilparencel resulted in a 4.6 mL/min/1.73m2 (78%) improvement in the annual decline of estimated glomerular filtration rate (eGFR) slope in Group 1 (n=24) patients No ...

November 6, 2025 Copenhagen, Denmark; Interim Report for the Nine Months Ended September 30, 2025. Highlights. Announcement of Genmab’s proposed acquisition of Merus N.V. (Merus ...

Revenue by product segment and geography Revenue grew from DKK 115.6 million to DKK 124.6 million in Q1 2025/26, a year-on-year increase of 8% that was driven by higher sales of instruments, ...